Subpoenas Forthcoming

Later today, a congressional subcommittee will vote on whether to issue subpoenas to several investigators regarding fraudulent trials of the antibiotic Ketek, and its subsequent marketplace approval by the FDA. The subcommittee’s leaders have alleged the drug’s approval moved forward despite the agency’s knowledge of the fraud.

One of the investigators that may be subpoenaed is GAP client Ann-Marie Cisneros, who testified in Congress last year that Ketek maker Sanofi-Aventis knew of the fraudulent trials.

-- Dylan Blaylock